Synairgen plc (AIM:SNG)
London
· Delayed Price · Currency is GBP · Price in GBX 0.8358
-0.0642 (-7.13%)
Mar 31, 2025, 1:44 PM GMT+1
Synairgen Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
10.67M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Synairgen News
- 6 days ago - AIM Market Roundup: European Metals, CMO, Empyrean - The Armchair Trader
- 19 days ago - AIM Market Roundup: CMO, Tungsten West, Rockfire - The Armchair Trader
- 20 days ago - AIM Market Roundup: GCM Resources, Deltic Energy, Solid State - The Armchair Trader
- 2 months ago - AIM Market Roundup: Mkango, N4 Pharma, Minoan - The Armchair Trader
- 3 months ago - Small Cap Stocks: Borders & Southern, GENIP, Smarttech 247 - The Armchair Trader